Follicular fluid-derived exosomes rejuvenate ovarian aging through miR-320a-3p-mediated FOXQ1 inhibition

Abstract

Ovarian aging is mainly characterized by a progressive decline in oocyte quantity and quality, which ultimately leads to female infertility. Various therapies have been established to cope with ovarian aging, among which exosome-based therapy is considered a promising strategy that can benefit ovarian functions via multiple pathways. Here, we isolated and characterized exosomes derived from ovarian follicular fluid and profiled the differential expression patterns of noncoding exosomal RNAs in young and aged women. Treatment with young mouse-derived exosomes efficiently rescued ovarian function in aged mice. The follicular fluid exosomes from young mice and miR-320-3p can also promote the proliferation of ovarian granulosa cells and improve mitochondrial function from old mice in vitro. The mechanism may be involve that exosomes transfer miR-320-3p to granulosa cells, and inhibit the expression of FOXQ1. Exosomes also can increase the number of primordial and growing follicles, and improve the developmental ability of oocytes in the old mice in vivo. And hnRNPA2B1 controls miR-320-3p entry into exosomes. This work provides insights into the antiaging potential of follicular fluid-derived exosomes and the underlying molecular mechanisms, which may facilitate prevention of ovarian aging and an improvement in female fertility.

Keywords

exosome / granulosa cells / miRNAs / ovarian aging / follicular fluid

References

[1] Farquhar CM, Bhattacharya S, Repping S, et al. Female subfertility. Nat Rev Dis Primers 2019;5:7.

[2] Sunderam S, Chang J, Flowers L, et al; Centers for Disease Control and Prevention (CDC). Assisted reproductive technology surveillance—United States, 2006. MMWR Surveill Summ 2009;58:1–25.

[3] Vollset SE, Goren E, Yuan CW, et al. Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study. Lancet 2020;396:1285–306.

[4] Zhai J, Zhang J, Zhang L, et al. Autotransplantation of the ovarian cortex after in-vitro activation for infertility treatment: a shortened procedure. Hum Reprod 2021;36:2134–47.

[5] Wang L, Mei Q, Xie Q, et al. A comparative study of mesenchymal stem cells transplantation approach to antagonize age-associated ovarian hypofunction with consideration of safety and efficiency. J Adv Res 2022;38:245–59.

[6] Ding L, Yan G, Wang B, et al. Transplantation of UC-MSCs on collagen scaffold activates follicles in dormant ovaries of POF patients with long history of infertility. Sci China Life Sci 2018;61:1554–65.

[7] Jeppesen DK, Fenix AM, Franklin JL, et al. Reassessment of exosome composition. Cell 2019;177:428–45.e18.

[8] Colombo M, Moita C, van Niel G, et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci 2013;126:5553–65.

[9] Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA 2004;101:13368–73.

[10] Ronquist G, Brody I. The prostasome: its secretion and function in man. Biochim Biophys Acta 1985;822:203–18.

[11] Ogawa Y, Miura Y, Harazono A, et al. Proteomic analysis of two types of exosomes in human whole saliva. Biol Pharm Bull 2011;34:13–23.

[12] Andre F, Schartz NE, Movassagh M, et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 2002;360:295–305.

[13] Caby MP, Lankar D, Vincendeau-Scherrer C, et al. Exosomallike vesicles are present in human blood plasma. Int Immunol 2005;17:879–87.

[14] Vella LJ, Sharples RA, Lawson VA, et al. Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol 2007;211:582–90.

[15] Admyre C, Johansson SM, Qazi KR, et al. Exosomes with immune modulatory features are present in human breast milk. J Immunol 2007;179:1969–78.

[16] Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013;200:373–83.

[17] Lee BR, Kim JH, Choi ES, et al. Effect of young exosomes injected in aged mice. Int J Nanomedicine 2018;13:5335–45.

[18] Lei Q, Gao F, Liu T, et al. Extracellular vesicles deposit PCNA to rejuvenate aged bone marrow-derived mesenchymal stem cells and slow age-related degeneration. Sci Transl Med 2021;13:eaaz8697.

[19] Villeda SA, Plambeck KE, Middeldorp J, et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat Med 2014;20:659–63.

[20] Rodrigues TA, Tuna KM, Alli AA, et al. Follicular fluid exosomes act on the bovine oocyte to improve oocyte competence to support development and survival to heat shock. Reprod Fertil Dev 2019;31:888–97.

[21] da Silveira JC, Veeramachaneni DN, Winger QA, et al. Cell-secreted vesicles in equine ovarian follicular fluid contain miRNAs and proteins: a possible new form of cell communication within the ovarian follicle. Biol Reprod 2012;86:71.

[22] da Silveira JC, de Ávila A, Garrett HL, et al. Cell-secreted vesicles containing microRNAs as regulators of gamete maturation. J Endocrinol 2018;236:R15–r27.

[23] Wei Z, Batagov AO, Schinelli S, et al. Coding and noncoding landscape of extracellular RNA released by human glioma stem cells. Nat Commun 2017;8:1145.

[24] Koga Y, Yasunaga M, Moriya Y, et al. Exosome can prevent RNase from degrading microRNA in feces. J Gastrointest Oncol 2011;2:215–22.

[25] Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction 2006;132:191–206.

[26] Sohel MM, Hoelker M, Noferesti SS, et al. Exosomal and non-exosomal transport of extra-cellular microRNAs in follicular fluid: implications for bovine oocyte developmental competence. PLoS One 2013;8:e78505.

[27] Diez-Fraile A, Lammens T, Tilleman K, et al. Age-associated differential microRNA levels in human follicular fluid reveal pathways potentially determining fertility and success of in vitro fertilization. Hum Fertil 2014;17:90–8.

[28] Chang HM, Qiao J, Leung PC. Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factors. Hum Reprod Update 2016;23:1–18.

[29] Gilchrist RB, Ritter LJ, Armstrong DT. Oocyte-somatic cell interactions during follicle development in mammals. Anim Reprod Sci 2004;82-83:431–46.

[30] Raviv S, Hantisteanu S, Sharon SM, et al. Lipid droplets in granulosa cells are correlated with reduced pregnancy rates. J Ovarian Res. 2020;13:4.

[31] Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 2003;14:281–7.

[32] Yang W, Zhang J, Xu B, et al. HucMSC-derived exosomes mitigate the age-related retardation of fertility in female mice. Mol Ther 2020;28:1200–13.

[33] Zhang Z, Xing T, Chen Y, et al. Exosome-mediated miR-200b promotes colorectal cancer proliferation upon TGF-β1 exposure. Biomed Pharmacother 2018;106:1135–43.

[34] Manna I, Iaccino E, Dattilo V, et al. Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients. FASEB J 2018;32:4241–6.

[35] Wang X, Zhou Y, Gao Q, et al. The role of exosomal microRNAs and oxidative stress in neurodegenerative diseases. Oxid Med Cell Longev. 2020;2020:3232869.

[36] Vishnoi A, Rani S. MiRNA biogenesis and regulation of diseases: an overview. Methods Mol Biol 2017;1509:1–10.

[37] Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010;79:351–79.

[38] Cai Y, Yu X, Hu S, et al. A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics 2009;7:147–54.

[39] Au Yeung CL, Co NN, Tsuruga T, et al. Exosomal transfer of stromaderived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. Nat Commun 2016;7:11150.

[40] Sun Q, Liang R, Li M, et al. Circ_UTRN ameliorates caeruleininduced acute pancreatitis in vitro via reducing inflammation and promoting apoptosis through miR-320-3p/PTK2 axis. J Pharm Pharmacol 2022;74:861–8.

[41] Nguyen MT, Lee W. MiR-320-3p regulates the proliferation and differentiation of myogenic progenitor cells by modulating actin remodeling. Int J Mol Sci 2022;23:801.

[42] Ding D, Jiang H, He Y, et al. miR-320-3p regulates the proliferation, migration and apoptosis of hypoxia-induced pulmonary arterial smooth muscle cells via KLF5 and HIF1α. Am J Transl Res. 2021;13:2283–95.

[43] Groot M, Lee H. Sorting mechanisms for MicroRNAs into extracellular vesicles and their associated diseases. Cells 2020;9:1044.

[44] O’Brien K, Breyne K, Ughetto S, et al. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat Rev Mol Cell Biol 2020;21:585–606.

[45] Santangelo L, Giurato G, Cicchini C, et al. The RNA-binding protein SYNCRIP is a component of the hepatocyte exosomal machinery controlling microrna sorting. Cell Rep. 2016;17:799–808.

[46] Li C, Qin F, Wang W, et al. hnRNPA2B1-mediated extracellular vesicles sorting of miR-122-5p potentially promotes lung cancer progression. Int J Mol Sci 2021;22:12866.

[47] Villarroya-Beltri C, Gutiérrez-Vázquez C, Sánchez-Cabo F, et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun 2013;4:2980.

RIGHTS & PERMISSIONS

The Author(s) 2024. Published by Oxford University Press on behalf of Higher Education Press.